Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

288

HTML

2138

Figures (1-3)

224

Tables (1-2)

196

Sum=2846

Jul 21, 2007 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 21, 2007; 13(27): 3726-3729
Published online Jul 21, 2007. doi: 10.3748/wjg.v13.i27.3726

Full Size Figure Download Figure

Figure 2 Cytoplasmic immunpositivity of ezrin in poorly differentiated gastric adenocarcinoma (IHC, x 200).

Citation: Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselçuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13(27): 3726-3729
URL: https://www.wjgnet.com/1007-9327/full/v13/i27/3726.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i27.3726